Cathie Biga, vice president of the American College of Cardiology, spoke to Cardiovascular Business at ACC.23 about challenges in the world of cardiology reimbursements. "As that healthcare dollar goes up, it is not going to the physicians," she said.

A teenager went into cardiac arrest on an American Airlines flight from Honduras to Miami. He never recovered, and now his family has filed a new lawsuit that blames the airline.

Diving deeper into the data, researchers noted that 40.8% of the payments were tied to speaker fees. Another 19% were from consulting fees.

The round was led by two new investors, Novo Holdings and Andera Partners. Several existing investors, including Medtronic, also participated.

American College of Cardiology Vice President Cathie Biga spoke to Cardiovascular Business about why the organization wants to get more involved in the business side of cardiology.

The annual list, now in its 17th year, was designed to celebrate companies that make ethical business practices a high priority. 

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 

The CEO of Cardiovascular Associates of America, and former CEO of the American College of Cardiology, shared his perspective on the rise of private equity investments in cardiology.